Quantcast

Latest Sickle-cell disease Stories

2014-09-10 12:28:16

Experts available to comment on disease, new patient-care recommendations for coverage this month WASHINGTON, Sept. 10, 2014 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH), the world's largest professional society concerned with the causes and treatment of blood disorders, celebrates research accomplishments in sickle cell disease (SCD) and calls for more research to better treat this debilitating disorder during National Sickle Cell Disease Awareness Month....

2014-09-09 16:26:45

Report illuminates important evidence gaps, Society calls for more research WASHINGTON, Sept. 9, 2014 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH), the world's largest professional organization dedicated to the causes and treatments of blood disorders, today endorsed a new evidence-based expert panel report on the management of sickle cell disease published by the National Heart, Lung, and Blood Institute (NHLBI) aimed at improving the care of patients with...

Faster, Cheaper Test Developed For Sickle Cell Disease
2014-09-02 03:27:42

Harvard University Newly developed test can identify sickle cell disease in minutes and could be used in rural clinics around the globe Within minutes after birth, every child in the US undergoes a battery of tests designed to diagnose a host of conditions, including sickle cell disease. Thousands of children born in the developing world, however, aren't so lucky, meaning many suffer and die from the disease each year. A.J. Kumar hopes to put a halt to at least some of those deaths....

2014-09-01 16:22:40

LONDON, Sept. 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Sickle Cell Disease Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/689745/Sickle-Cell-Disease-Global-Clinical-Trials-Review-H2-2014.html Sickle Cell Disease Global Clinical Trials Review, H2, 2014 SummaryGlobalData's clinical trial report, "Sickle Cell Disease Global Clinical Trials Review, H2, 2014" provides data on the Sickle Cell Disease clinical trial...

2014-08-28 12:29:36

MILWAUKEE, Aug. 28, 2014 /PRNewswire-USNewswire/ -- BloodCenter of Wisconsin's Diagnostic Laboratories today announced the availability of an innovative Erythroid Chimerism test to monitor erythroid lineage chimerism in patients with sickle cell disease (SCD) following allogeneic bone marrow transplantation. This allows the physician to directly gauge the success of the transplant in these patients and provides physicians with actionable information to guide patient care. Sickle cell...

2014-08-11 12:28:08

Four-year, $2.5 Million Study Could Directly Benefit Patients with Sickle Cell Disease NEW YORK, Aug. 11, 2014 /PRNewswire-USNewswire/ -- For patients with sickle cell disease (SCD), blood transfusions remain a cornerstone of treatment, with 60-90% of patients receiving red blood cell (RBC) transfusions in their lifetime. Despite provision of extended antigen-matched donor RBCs, as many as two-thirds of the patients continue to develop antibodies against polymorphic antigens on...

2014-07-16 08:26:59

KINDU, Democratic Republic Of The Congo, July 16, 2014 /PRNewswire/ -- It is estimated that 25 percent of Congolese adults have sickle cell anemia trait, a debilitating disease of the blood transmitted genetically to newborn children. Of the 50,000 Congolese children born annually with sickle cell, 75 percent will die before age two. Support from the Gertler Family Foundation [http://www.gertlerfamilyfoundation.org ] (GFF) is saving the lives of hundreds of these children and...

2014-07-02 23:02:01

A potentially groundbreaking investigational drug designed to treat the painful vaso-occlusive crises that are the hallmark of sickle cell disease has been found to be safe following a clinical trial at UC Davis. Sacramento, CA (PRWEB) July 02, 2014 A potentially groundbreaking investigational drug designed to treat the painful vaso-occlusive crises that are the hallmark of sickle cell disease has been found to be safe following a clinical trial at UC Davis. Vaso-occlusive crises, during...

2014-07-02 12:51:45

NIH/National Institute of Diabetes and Digestive and Kidney Diseases Adults stop anti-rejection drugs after stem-cell transplant reverses sickle cell disease NIH trial success suggests a new treatment option for older, sicker patients Half of patients in a trial have safely stopped immunosuppressant medication following a modified blood stem-cell transplant for severe sickle cell disease, according to a study in the July 1 issue of the Journal of the American Medical Association. The...

2014-07-02 12:12:20

The JAMA Network Journals Use of a lower intensity bone marrow transplantation method showed promising results among 30 patients (16-65 years of age) with severe sickle cell disease, according to a study in the July 2 issue of JAMA. Myeloablative (use of high-dose chemotherapy or radiation) allogeneic hematopoietic stem cell transplantation (HSCT; receipt of hematopoietic stem cells "bone marrow" from another individual) is curative for children with severe sickle cell disease, but...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related